Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Registries in systemic sclerosis: a worldwide experience.

Galluccio F, Walker UA, Nihtyanova S, Moinzadeh P, Hunzelmann N, Krieg T, Steen V, Baron M, Sampaio-Barros P, Kayser C, Nash P, Denton CP, Tyndall A, Müller-Ladner U, Matucci-Cerinic M.

Rheumatology (Oxford). 2011 Jan;50(1):60-8. doi: 10.1093/rheumatology/keq355. Review.

PMID:
21148153
2.

The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma research.

Tyndall A, Ladner UM, Matucci-Cerinic M.

Curr Opin Rheumatol. 2008 Nov;20(6):703-6. doi: 10.1097/BOR.0b013e328311f841. Review.

PMID:
18946332
3.

EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research.

Beyer C, Distler JH, Allanore Y, Aringer M, Avouac J, Czirják L, Cutolo M, Damjanov N, Del Galdo F, Fligelstone K, Guiducci S, Kowal-Bielecka O, van Laar JM, Martucci-Cerinic M, Müller-Ladner U, Riemekasten G, Tarner IH, Tyndall A, Kennedy AT, Valentini G, Vettori S, Walker UA, Denton C, Distler O; EUSTAR Biobanking Group.

Ann Rheum Dis. 2011 Jul;70(7):1178-82. doi: 10.1136/ard.2010.142489. Epub 2011 Feb 1.

PMID:
21285118
4.

European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.

Avouac J, Kowal-Bielecka O, Landewe R, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Coauthors.

Ann Rheum Dis. 2009 May;68(5):629-34. doi: 10.1136/ard.2008.095299. Epub 2008 Oct 28.

PMID:
18957486
5.

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Co-Authors.

Ann Rheum Dis. 2009 May;68(5):620-8. doi: 10.1136/ard.2008.096677. Epub 2009 Jan 15.

PMID:
19147617
6.

Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database.

Walker UA, Tyndall A, Czirják L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Matucci-Cerinic M; EUSTAR co-authors.

Ann Rheum Dis. 2009 Jun;68(6):856-62. doi: 10.1136/ard.2008.091348. Epub 2008 Jul 14.

PMID:
18625615
7.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

8.

[The German network for systemic sclerosis (DNSS): current data on diagnostics and therapy].

Hunzelmann N, Krieg T; Kooperationspartner der DNSS.

Hautarzt. 2012 Apr;63 Suppl 1:71-5. doi: 10.1007/s00105-011-2300-0. Review. German.

PMID:
22543950
9.

Analysis of outcomes for congenital cardiac disease: can we do better?

Jacobs JP, Wernovsky G, Elliott MJ.

Cardiol Young. 2007 Sep;17 Suppl 2:145-58. doi: 10.1017/S1047951107001278. Review.

PMID:
18039408
10.

Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?

Müller-Ladner U, Tyndall A, Czirjak L, Denton C, Matucci-Cerinic M; EUSTAR centres.

Ann Rheum Dis. 2014 Feb;73(2):324-7. doi: 10.1136/annrheumdis-2013-203997. Epub 2013 Oct 11.

PMID:
24121165
11.

European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.

Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Becvar R, Bruhlman P, Cozzi F, Czirják L, Drosos AA, Dziankowska B, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Scorza R, Tirri E, van den Hoogen FH, Vlachoyiannopoulos PG.

Ann Rheum Dis. 2001 Jun;60(6):585-91.

12.

Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database.

Baron M, Hudson M, Steele R; Canadian Scleroderma Research Group.

J Rheumatol. 2009 Dec;36(12):2737-43. doi: 10.3899/jrheum.090694. Epub 2009 Oct 15.

PMID:
19833750
13.

Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry.

Tsakiris D, Simpson HK, Jones EH, Briggs JD, Elinder CG, Mendel S, Piccoli G, dos Santos JP, Tognoni G, Vanrenterghem Y, Valderrabano F.

Nephrol Dial Transplant. 1996;11 Suppl 7:4-20.

PMID:
9067983
14.

Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.

[No authors listed]

Drugs R D. 2005;6(3):178-85. Review.

PMID:
15869322
15.

Work disability in systemic sclerosis.

Hudson M, Steele R, Lu Y, Thombs BD; Canadian Scleroderma Research Group, Baron M.

J Rheumatol. 2009 Nov;36(11):2481-6. doi: 10.3899/jrheum.081237. Epub 2009 Oct 1.

PMID:
19797513
16.

Congenital heart surgery databases around the world: do we need a global database?

Jacobs JP, Maruszewski B, Kurosawa H, Jacobs ML, Mavroudis C, Lacour-Gayet FG, Tchervenkov CI, Walters H 3rd, Stellin G, Ebels T, Tsang VT, Elliott MJ, Murakami A, Sano S, Mayer JE Jr, Edwards FH, Quintessenza JA.

Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2010;13(1):3-19. doi: 10.1053/j.pcsu.2010.02.003.

PMID:
20307856
17.

[Towards an implementation of guidelines for the therapy of systemic sclerosis (scleroderma): between desire and reality].

Becker MO, Müller-Ladner U, Riemekasten G.

Z Rheumatol. 2010 Jun;69(4):310-7. doi: 10.1007/s00393-009-0523-6. German.

PMID:
20490516
18.

Management of cutaneous vascular complications in systemic scleroderma: experience from the German network.

Herrgott I, Riemekasten G, Hunzelmann N, Sunderkötter C.

Rheumatol Int. 2008 Aug;28(10):1023-9. doi: 10.1007/s00296-008-0556-1. Epub 2008 Mar 5.

PMID:
18320192
19.

Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients.

Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M; Canadian Scleroderma Research Group.

Arthritis Rheum. 2009 Jul 15;61(7):966-73. doi: 10.1002/art.24614.

20.

The association between disease activity and duration in systemic sclerosis.

Walker JG, Steele RJ, Schnitzer M, Taillefer S, Baron M; Canadian Scleroderma Research Group, Hudson M.

J Rheumatol. 2010 Nov;37(11):2299-306. doi: 10.3899/jrheum.090919. Epub 2010 Sep 1.

PMID:
20810506

Supplemental Content

Support Center